GLYCOMIRA LLC
DOVER, Delaware
Total Received
$7.8M
Total Awards
3
State
Delaware
Last Updated
Jun 5, 2025
Top 3 Awards to GLYCOMIRA LLC
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through June 5, 2025.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_R44AI126987_075 A NOVEL GLYCOSAMINOGLYCAN-BASED THERAPEUTIC FOR CHRONIC RHINOSINUSITIS - PROJECT SUMMARY CHRONIC RHINOSINUSITIS (CRS) IS ONE OF THE MOST PREVALENT INFLAMMATORY DISEASES IN THE U.S… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | UT-90 | 2025 | $4,382,830 |
ASST_NON_SB1DE024024_075 GLYCOSAMINOGLYCANS TO TREAT AND PREVENT RADIATION-INDUCED ORAL MUCOSITIS - PROJECT SUMMARY/ABSTRACT ORAL MUCOSITIS IS A DEVASTATINGLY PAINFUL INFLAMMATORY DISEASE THAT FREQUENTLY… | Department of Health and Human Services National Institutes of Health | 93.121 ORAL DISEASES AND DISORDERS RESEARCH | UT-90 | 2025 | $2,826,053 |
ASST_NON_R41AI179525_075 DEVELOPMENT OF A DIAGNOSTIC TEST FOR EOSINOPHILIC CHRONIC RHINOSINUSITIS - PROJECT SUMMARY THE GOAL OF THIS PROPOSAL IS TO OPTIMIZE AND CLINICALLY VALIDATE A NEW DIAGNOSTIC TEST… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SALT LAKE CITY, UT-01 | 2024 | $595,272 |
Top 3 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Source: USAspending.gov · All Recipients · Delaware